SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
134,000
-2,300 (-1.69%)
At close: Dec 5, 2025

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 10.49 trillion as of December 5, 2025. Its market cap has increased by 19.64% in one year.

Market Cap
10.49T
Enterprise Value
10.30T
Revenue
675.41B
Ranking
n/a
PE Ratio
32.75
Stock Price
134,000.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has increased from 9.95T to 10.49T, an increase of 5.51%. That is a compound annual growth rate of 0.99%.

History

DateMarket Cap% Change
Dec 5, 202510.49T20.61%
Dec 30, 20248,700.60B10.66%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 76.57T
Celltrion 40.30T
ALTEOGEN 27.86T
ABL Bio 11.08T
Yuhan 8,911.91B
LigaChem Biosciences 6,907.33B
Peptron 6,668.76B
HLB Co., Ltd. 6,394.65B
Market Cap Rankings